You have 9 free searches left this month | for more free features.

City

Condition

Metastatic Castration-Resistant Prostate Cancer (mCRPC) (1)

Oligometastatic Prostate Cancer (OMPC) (1)

Prostate Cancer (1)

Prostatic Neoplasm (1)

Overall Status

Not yet recruiting (4)

Sign in for free

Phase

phase 2 (2)

phase 3 (1)

phase 4 (1)

Sponsor

Novartis Pharmaceuticals (4)

Collaborator

Intervention

aaa617 (4)

68ga-psma-11 (1)

aaa517 (1)

adt (1)

arpi (1)

best supportive care (1)

piflufolastat f 18 (1)

Study Documents

Intervention Type

drug (4)

other (1)

Funder Type

Industry (4)

Study Type

Interventional (4)

aaa617

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Prostatic Tumor Trial (AAA617, AAA517, Piflufolastat F 18)

Not yet recruiting

Prostatic Neoplasm

AAA617
+5 more

(no location specified)

Apr 27, 2023

Oligometastatic Prostate Cancer (OMPC) Trial (AAA617)

Not yet recruiting

Oligometastatic Prostate Cancer (OMPC)

AAA617

(no location specified)

Jul 3, 2023

Prostate Cancer Trial (AAA617)

Not yet recruiting

Prostate Cancer

AAA617

(no location specified)

Mar 27, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (AAA617, 68Ga-PSMA-11)

Not yet recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

AAA617
68Ga-PSMA-11

(no location specified)

Aug 16, 2023